Sonosa Medical, Inc. spins out of the MDC Studio to develop next-generation devices poised to transform the treatment pathway of obstructive sleep apnea

BALTIMORE, Aug. 20, 2021 /PRNewswire-PRWeb/ -- The MDC Studio is pleased to announce the spin-out of the company, Sonosa Medical, Inc., as an independent entity. Founded in 2019, Sonosa Medical is developing next-generation devices poised to transform the diagnosis and treatment of obstructive sleep apnea (OSA). The company is led by Dr. Stephen Restaino as Chief Executive Officer, Dr. Jeffrey Wolf as Medical Advisor, and Dr. Gil Blankenship as Chairman of the Board. Dr. Restaino and his team have been developing novel technologies for the detection and treatment of OSA using a wearable device. Their work has been funded by a $3.35 million Phase II Small Business Innovation Research (SBIR) award from the Defense Advanced Research Projects Agency (DARPA).

Dr. Restaino is also the Director of Engineering and a Partner at the MDC Studio, and has been involved in developing every technology at the MDC Studio since joining in 2017. Dr. Jeffrey Wolf is a Partner at the MDC Studio, as well as a Professor of Otorhinolaryngology – Head and Neck Surgery and Program in Oncology at the University of Maryland Medical System. Dr. Blankenship is the Founder and Chief Executive Officer of the MDC Studio, and a Professor of Electrical and Computer Engineering at the University of Maryland. The MDC Studio is dedicated to building health and medical technology companies based on intellectual property from top-tier research programs in Maryland.

"Stephen has played a critical role in developing the Sonosa technology and launching the company, and the MDC Studio looks forward to continuing to support the team and develop devices to revolutionize the treatment pathway for almost one billion patients worldwide with OSA," said Dr. Blankenship.

"Support from the MDC Studio has been critical to the success of the Sonosa project and to the development of the Sonosa Medical company. The MDC Studio's structure of engineering development complemented by business development and support services has allowed Sonosa Medical to develop both its technology and its company structure in parallel," said Dr. Restaino.

About Sonosa Medical
Sonosa Medical, Inc. is developing wearable devices to improve the diagnosis and treatment of OSA. The Company has developed a novel non-invasive technology that can both locate the source of an airway obstruction during sleep and provide measures to maintain an open airway, allowing patients to sleep normally. The development of the Company's technology has been funded by DARPA via an SBIR contract.

About the MDC Studio
The MDC Studio is the operational unit of the Maryland Development Center Partnership, which was founded in 2016 in Baltimore, Maryland. The MDC Studio functions as a MedTech Startup Studio that provides engineering support, business development services, and funding to create and support companies commercializing medical devices. The Studio works with inventors to develop their ideas into working prototypes and marketable products, and form companies that will grow and create value for both their shareholders and all of society. The MDC Studio-Baltimore is located in the historic Wilkens-Robins building in the heart of Baltimore, near the University of Maryland Medical Center and Johns Hopkins Hospital, where MDC's founding partners and affiliates practice, teach, and research state-of-the-art surgery and medicine.

Media Contact

Nao Gamo, MDC Studio Inc., 1 6173190394, [email protected]

SOURCE MDC Studio Inc.